Q&A – TRIPLE NEGATIVE BREAST CANCER on Tuesday 24th October from 4:30-6pm (AEDT).
Register for the Q&A on Triple Negative Breast Cancer (Submit a question.) https://www.breastcancertrials.org.au/news/qa-events/qa-triple-negative-breast-cancer/ Triple negative breast cancer accounts for approximately 15% of all breast cancers. As the name suggests, triple negative breast cancer does not have any of the three receptors that are commonly found on breast cancer cells – oestrogen, progesterone and HER2 receptors. Anyone can be diagnosed with triple negative breast cancer but it occurs more often in younger patients who are pre-menopausal or under 50 years of age. People with a BRCA1 gene mutation also have a higher risk of this type of breast cancer. Triple negative breast cancer is a more aggressive type of tumour, with a faster growth rate, a higher risk of spreading to other parts of the body (metastasis) and of recurrence either in the breast or elsewhere. Because it does not have any of the more common receptors that can be targeted by medications, such as hormone and HER2-blocking drugs, it has fewer treatment options available. Standard treatment of early stage triple negative breast cancer typically includes chemotherapy, surgery and in many cases a course of radiotherapy. Often chemotherapy treatment is given prior to breast surgery (neoadjuvant chemotherapy), as it can effectively reduce the size of the breast cancer while providing useful information about the effectiveness of the treatment being given. Breast Cancer Trials has been researching new and better treatments for triple negative breast cancer. The CHARIOT clinical trial examined the addition of dual immunotherapy to standard chemotherapy and showed promising results in patients with treatment resistant, early-stage triple negative breast cancer. The Neo-N clinical trial is investigating whether using an immunotherapy drug together with chemotherapy, is safe and effective in treating breast cancer before surgery. Results of this study are expected later this year. Join our panel of experts as we explore triple negative breast cancer. We’ll hear firsthand from women who have a history of this type of cancer, and from world-leading researchers on the latest in research and clinical trials to improve treatments and patient outcomesBreast Cancer & Fertility - a Q&A Webinar - 20th Feb, 5 - 6.30pm
For those interested in Breast Cancer & Fertility - register for this webinar on Feb 20th. Around 4,000 women in Australia under the age of 45 are diagnosed with breast cancer each year. For those in their childbearing years decisions about treatment need to consider fertility, as treatments such as chemotherapy and hormone therapy may induce premature menopause and can reduce a woman’s chance of having children. Moderated by author and journalist Annabel Crabb, the panel of experts will discuss fertility preservation options, informed decision making, and the latest research – including the POEMS clinical trial, which your support has made possible. https://www.breastcancertrials.org.au/news/qa-events/qa-breast-cancer-and-fertility/Dr Liz O'Riordan talks about her surgeries & aftermath - A UK Breast Surgeon with Breast Cancer
Dr Liz O'Riordan was diagnosed with breast cancer some years after qualifying as a breast cancer surgeon & realised that whilst she knew some of the physical effects of Breast Cancer surgery - she really was not prepared for the psychological (and indeed actual physical limitations) that she experienced, once she'd had her own surgery, chemo, rads etc - she also suffered from extreme cording that restricted her arm movement. Eventually, after a recurrence and more surgery, it prevented her from continuing as a Breast Surgeon. This is a more recent write up : https://www.nzherald.co.nz/lifestyle/dr-liz-oriordan-im-a-breast-cancer-surgeon-this-is-what-surviving-cancer-myself-taught-me/GWGO5EWTRNFAHB7MLHU5SGPTIM/ In her own 'blog' - she writes candidly - from her own diagnosis, surgery, chemo, tabs & treatment overall with all the same fears and side effects that many of us have experienced .... Read her personal story here (then click on her 'blog': http://liz.oriordan.co.uk/ You can follow her on Instagram too https://www.instagram.com/oriordanliz - work your way thru her videos ..... they are authentic & helpful She has announced a New trial in the UK, attempting to identify younger women with higher risk of breast cancer BEFORE diagnosis - particularly those with dense breast tissue .... leading to earlier intensive testing before the 'normal age' of 40 https://www.instagram.com ; /p/Ct_-RRUINgJ/. (copy & join these 2 parts of the link, to see it as it won't load here.) Nina Lopez (who Liz interviews in one of the videos - add 'this link' after the '.instagram.com bit ... p/Ct2ESwoIkwn/) who talks about HER triple Negative BC here: https://www.the-c-list.com/stories/nina-lopez-39-shares-her-story-of-motherhood-treatment-and-resilience-as-she-lives-with-secondary-breast-cancer And below, are some of the subjects that she covers on Instagram ..
